ArticleFrontiers in bioengineering and biotechnology2026
Improving governance in the age of synthetic biology, artificial intelligence, and diverging threats.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Governing synthetic biology and artificial intelligence (AI) convergence: emerging biosecurity priorities for Africa.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Advancements in synthetic biology (SynBio) and other emerging and converging technologies, such as artificial intelligence (AI) additive manufacturing (3D printing), and nanotechnology are driving progress at an unprecedented pace. However, these promising and groundbreaking advances could also lead to novel biological risks, including the potential development of SynBio-enabled bioweapons (BW). Methods: Conducting a Delphi process, we consulted 13 experts from diverse relevant sectors. The multi-stage process included insights from literature reviews, expert interviews, two rounds of expert surveys, and two workshops. Results: We identified consistent biological threat prioritizations and established consensus-driven policy recommendations. Based on this, we developed a novel hybrid governance framework. Our key proposal includes a multifaceted and integrative approach involving four sequential, iterative components: raising awareness; establishing robust training and monitoring systems to improve biosecurity measures; developing and implementing agile governance frameworks; and strengthening international treaties, such as the Biological Weapons Convention (BWC). Conclusion: We consider these integral, interconnected components to be interdependent and equally important. In an era of SynBio, AI-driven bioengineering, and democratization of biotechnology, implementing these recommendations will better safeguard against the potential misuse of these advancements in the context of the development and proliferation of BW.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.